Soe Y, Sim S, Kumari S
Viruses. 2025; 17(2).
PMID: 40006996
PMC: 11861910.
DOI: 10.3390/v17020241.
Nelson A, Wang L, Laffey K, Becher L, Parks C, Hoffmann M
Front Immunol. 2024; 15:1434463.
PMID: 39281668
PMC: 11392757.
DOI: 10.3389/fimmu.2024.1434463.
Du Y, Wu J, Liu J, Zheng X, Yang D, Lu M
Front Immunol. 2022; 13:965018.
PMID: 35967443
PMC: 9372436.
DOI: 10.3389/fimmu.2022.965018.
Zhang M, Slaby E, Stephanie G, Yu C, Watts D, Liu H
Front Immunol. 2020; 11:560.
PMID: 32425924
PMC: 7212467.
DOI: 10.3389/fimmu.2020.00560.
Javaid N, Choi S
Cancers (Basel). 2020; 12(2).
PMID: 32012718
PMC: 7072551.
DOI: 10.3390/cancers12020297.
Brain microglia activation induced by intracranial administration of oligonucleotides and its pharmacological modulation.
La Maestra S, Frosina G, Micale R, DOria C, Garibaldi S, Daga A
Drug Deliv Transl Res. 2018; 8(5):1345-1354.
PMID: 29869293
DOI: 10.1007/s13346-018-0535-3.
Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
Ma Z, Cao Q, Xiong Y, Zhang E, Lu M
Vaccines (Basel). 2018; 6(1).
PMID: 29337856
PMC: 5874647.
DOI: 10.3390/vaccines6010006.
Different interleukin-17-secreting Toll-like receptor T-cell subsets are associated with disease activity in multiple sclerosis.
Ferreira T, Hygino J, Wing A, Kasahara T, Sacramento P, Camargo S
Immunology. 2017; 154(2):239-252.
PMID: 29168181
PMC: 6381308.
DOI: 10.1111/imm.12872.
A Synthetic CD8α:MyD88 Coreceptor Enhances CD8 T-cell Responses to Weakly Immunogenic and Lowly Expressed Tumor Antigens.
Kaczanowska S, Mary Joseph A, Guo J, Tsai A, Lasola J, Younger K
Cancer Res. 2017; 77(24):7049-7058.
PMID: 29055013
PMC: 5732881.
DOI: 10.1158/0008-5472.CAN-17-0653.
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40.
Foster A, Mahendravada A, Shinners N, Chang W, Crisostomo J, Lu A
Mol Ther. 2017; 25(9):2176-2188.
PMID: 28697888
PMC: 5589084.
DOI: 10.1016/j.ymthe.2017.06.014.
FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4 T Cells.
Chauhan A
J Immunol. 2017; 198(12):4596-4606.
PMID: 28500073
PMC: 5505339.
DOI: 10.4049/jimmunol.1601954.
Extrinsic MAVS signaling is critical for Treg maintenance of Foxp3 expression following acute flavivirus infection.
da Costa A, Garza E, Graham J, Swarts J, Soerens A, Gale M
Sci Rep. 2017; 7:40720.
PMID: 28094802
PMC: 5240555.
DOI: 10.1038/srep40720.
T Cell Production of IFNγ in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses.
Rubtsova K, Rubtsov A, Halemano K, Li S, Kappler J, Santiago M
PLoS One. 2016; 11(11):e0166322.
PMID: 27880772
PMC: 5120817.
DOI: 10.1371/journal.pone.0166322.
Close Encounters of Lymphoid Cells and Bacteria.
Cruz-Adalia A, Veiga E
Front Immunol. 2016; 7:405.
PMID: 27774092
PMC: 5053978.
DOI: 10.3389/fimmu.2016.00405.
Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.
Lim J, Ryu D, Lee S, Park G, Choi E, Min C
Mol Cells. 2015; 38(11):966-74.
PMID: 26552489
PMC: 4673411.
DOI: 10.14348/molcells.2015.0158.
CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery.
Kheirolomoom A, Ingham E, Mahakian L, Tam S, Silvestrini M, Tumbale S
J Control Release. 2015; 220(Pt A):253-264.
PMID: 26471394
PMC: 4688109.
DOI: 10.1016/j.jconrel.2015.10.016.
Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.
Li Z, Younger K, Gartenhaus R, Mary Joseph A, Hu F, Baer M
J Clin Invest. 2015; 125(3):1081-97.
PMID: 25642772
PMC: 4362243.
DOI: 10.1172/JCI75821.
Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Ma Z, Zhang E, Yang D, Lu M
Cell Mol Immunol. 2014; 12(3):273-82.
PMID: 25418467
PMC: 4654312.
DOI: 10.1038/cmi.2014.112.
Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response.
Scott M, Ma Y, Farhat S, Moscicki A
Int J Cancer. 2014; 136(10):2402-8.
PMID: 25346143
PMC: 4355215.
DOI: 10.1002/ijc.29283.
Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.
Hickey A, Lin J, Kummer L, Szaba F, Duso D, Tighe M
Infect Immun. 2013; 81(6):2123-32.
PMID: 23545300
PMC: 3676034.
DOI: 10.1128/IAI.00316-13.